Advancements in Wastewater Monitoring for Rapid COVID-19 Community Spread Detection
Webinar Overview
The COVID-19 pandemic has taken a terrible toll on human life and economic stability. Early efforts have demonstrated that wastewater testing can monitor overall community infection trends and predict a coming outbreak or surge of infections.
For this timely webinar, In-Situ has partnered with GT Molecular and EcoLucid to share a wastewater monitoring solution that includes:
- A COVID testing method that is faster, less expensive, more sensitive and more secure than other methods
- Best practices for establishing an effective monitoring regime and developing data modelling and mapping methods for actionable results
- And recommended sampling equipment
Whether you’re currently monitoring wastewater for early detection of COVID-19 or interested in starting a sampling program, this discussion of an end-to-end solution that is both feasible and effective will support your efforts and help you get the best results.
- Overview of methods used to monitor COVID-19 levels in wastewater and why monitoring works
- Advantages of a molecular digital assay that uses digital PCR
- Other benefits of the GT Molecular method
- Techniques and approaches for using data effectively to inform decision making
- Statistical analysis of results
- Use of hydraulic modeling to make sense of data
- Combining sampling data, flow data, and real-time monitoring to get more meaningful results
- Recommendations for sampling equipment, including lease options
- Director of Plant Operations
- Environmental Specialists
- Analytical Services Officers
- Coordinators of Wastewater Treatment
- Deputy Directors
-
Directors of Strategy and Innovation
- Laboratory Support Supervisor
- District Engineers
- Process Engineerss
- Directors of Environmental Programs
- Clean Water Program Managers
Presenter: Dr. Rose Nash, Marcus Quigley and Scott Kahle
Dr. Rose Nash is the Director of Research and Development at GT Molecular where she leads development efforts for an ultrasensitive COVID-19 diagnostic that is currently pending FDA approval. Previously, Rose served as the R&D Manager at InDevR, a Boulder biotechnology company developing new molecular tools to serve the influenza vaccine industry. Her training includes a Bachelor’s degree in Microbiology from Indiana University, a Doctorate in Microbiology from the University of Wisconsin-Madison, and two post-doctoral fellowships at the University of Colorado-Boulder.
Marcus Quigley brings over 25 years of technical, business, and industry experience leading major programs and creating and growing organizations to solve our most urgent and complex civil and environmental problems. Marcus’ expertise includes civil and water resources engineering focusing on digital and intelligent systems, design, green infrastructure, water quality and hydrologic modeling and monitoring, data and statistical acquisition and analysis, and execution of major compliance auditing and litigation projects. Marcus is founder and CEO of EcoLucid, a Boston-based company working at the intersection of technology and practice.
Scott Kahle is VP of Process Analysis at ChemScan, Inc, an In-Situ Brand. As principle design engineer for the ChemScan product line, he developed and installed instrumentation for wastewater treatment using biological and chemical nutrient removal processes and for water treatment using the chloramination disinfection process in many major North American metropolitan areas. He has led multiple U.S. patents including “Water Chloramination Control Process.”